DK1309585T3 - Nye indolderivater og anvendelse af disse som lægemidler - Google Patents

Nye indolderivater og anvendelse af disse som lægemidler

Info

Publication number
DK1309585T3
DK1309585T3 DK01969522T DK01969522T DK1309585T3 DK 1309585 T3 DK1309585 T3 DK 1309585T3 DK 01969522 T DK01969522 T DK 01969522T DK 01969522 T DK01969522 T DK 01969522T DK 1309585 T3 DK1309585 T3 DK 1309585T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
indole derivatives
new indole
new
derivatives
Prior art date
Application number
DK01969522T
Other languages
Danish (da)
English (en)
Inventor
Silke Baasner
Peter Emig
Gerald Bacher
Dietmar Reichert
Beate Aue
Bernd Nickel
Eckhard Guenther
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1309585T3 publication Critical patent/DK1309585T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK01969522T 2000-07-28 2001-07-26 Nye indolderivater og anvendelse af disse som lægemidler DK1309585T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10037310A DE10037310A1 (de) 2000-07-28 2000-07-28 Neue Indolderivate und deren Verwendung als Arzneimittel
PCT/EP2001/008644 WO2002010152A2 (de) 2000-07-28 2001-07-26 Neue indolderivate und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DK1309585T3 true DK1309585T3 (da) 2008-06-23

Family

ID=7650860

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969522T DK1309585T3 (da) 2000-07-28 2001-07-26 Nye indolderivater og anvendelse af disse som lægemidler

Country Status (30)

Country Link
US (3) US7365081B2 (cs)
EP (3) EP1939195A1 (cs)
JP (1) JP5113973B2 (cs)
KR (1) KR100810453B1 (cs)
CN (1) CN1215066C (cs)
AR (1) AR055209A1 (cs)
AT (1) ATE392420T1 (cs)
AU (2) AU8975801A (cs)
BG (1) BG66457B1 (cs)
BR (1) BR0112807A (cs)
CA (3) CA2354210C (cs)
CY (1) CY1108770T1 (cs)
CZ (1) CZ304197B6 (cs)
DE (2) DE10037310A1 (cs)
DK (1) DK1309585T3 (cs)
ES (1) ES2303532T3 (cs)
HU (1) HU229254B1 (cs)
IL (2) IL153930A0 (cs)
MX (1) MXPA03000644A (cs)
NO (1) NO324594B1 (cs)
NZ (1) NZ524404A (cs)
PL (1) PL208673B1 (cs)
PT (1) PT1309585E (cs)
RU (1) RU2270196C9 (cs)
SI (1) SI1309585T1 (cs)
SK (1) SK288085B6 (cs)
TW (1) TWI291955B (cs)
UA (1) UA80670C2 (cs)
WO (1) WO2002010152A2 (cs)
ZA (1) ZA200300584B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52155013A (en) 1976-06-18 1977-12-23 Hitachi Ltd Image pickup unit
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
CA2460347A1 (en) 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer
US7205299B2 (en) * 2003-06-05 2007-04-17 Zentaris Gmbh Indole derivatives having an apoptosis-inducing effect
RU2327696C2 (ru) * 2003-06-05 2008-06-27 Центарис Гмбх Производные индола, обладающие индуцирующим апоптоз эффектом (варианты), фармацевтическая композиция на их основе
EP1484329A1 (de) * 2003-06-06 2004-12-08 Zentaris GmbH Indolderivate mit Apoptose induzierender Wirkung
US7211588B2 (en) * 2003-07-25 2007-05-01 Zentaris Gmbh N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
EA018724B1 (ru) 2006-08-07 2013-10-30 Айронвуд Фармасьютикалз, Инк. Соединения индола
CA2724726C (en) 2008-05-23 2018-02-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein inhibitor
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3632M (fr) 1962-10-31 1965-10-25 Thomae Gmbh Dr K Dérivés de l'acide 6-amino-pénicillanique.
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US3573294A (en) 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
US5192770A (en) 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
WO1996004266A2 (de) * 1994-08-03 1996-02-15 Asta Medica Aktiengesellschaft Indol-, indazol-, pyridopyrrol- und pyridopyrazol-derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender wirkung
US5732113A (en) 1996-06-20 1998-03-24 Stanford University Timing and frequency synchronization of OFDM signals
DE19636150A1 (de) 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
BR9908275A (pt) 1998-02-25 2000-10-24 Genetics Inst Inibidores de enzimas fosfolipase
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
DE19946301A1 (de) * 1998-04-02 2001-04-19 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
DE19814838C2 (de) 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
WO1999055896A1 (en) 1998-04-27 1999-11-04 Aventis Pharma Deutschland Gmbh A new glucose-6-phosphate translocase inhibitor l 970885 from an actinomycete sp., and chemical derivatives thereof, a process for the preparation and their use as pharmaceuticals
ES2262072T3 (es) 1998-04-28 2006-11-16 Elbion Ag Derivados de indol y su utilizacion como inhibidores de la fosfodiesterasa 4.
WO1999064044A1 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Novel therapeutic agents that modulate 5-ht receptors
CA2755266C (en) 1998-06-17 2014-08-12 Eisai R&D Management Co., Ltd. Intermediates for preparing macrocyclic analogs
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
WO2000031603A1 (de) * 1998-11-19 2000-06-02 Infineon Technologies Ag Schaltungsanordnung zum erzeugen einer stabilisierten versorgungsspannung für mehrere verbraucher
WO2000067802A1 (en) 1999-05-10 2000-11-16 Protarga, Inc. Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
DE60036868D1 (de) 1999-05-21 2007-12-06 Scios Inc Derivate des indol-typs als p38 kinase inhibitoren
EE200200065A (et) 1999-08-12 2003-04-15 Pharmacia Italia S.P.A. 3-aminopürasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena ning neid sisaldav farmatseutiline kompositsioon
ATE329920T1 (de) 1999-09-10 2006-07-15 Novo Nordisk As Modulatoren der protein tyrosin phosphatase (ptpases)
AU7476800A (en) 1999-09-10 2001-04-10 Novo Nordisk A/S Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
TWI269654B (en) 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action
IT1315267B1 (it) 1999-12-23 2003-02-03 Novuspharma Spa Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
DE19962300A1 (de) 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
WO2001094310A1 (en) 2000-06-07 2001-12-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Methods for making bis-heterocyclic alkaloids
DE10035927A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
IT1318641B1 (it) 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
US7205299B2 (en) * 2003-06-05 2007-04-17 Zentaris Gmbh Indole derivatives having an apoptosis-inducing effect
GB0525623D0 (en) 2005-12-16 2006-01-25 Hill Nicholas P R RFID reader
JPWO2008105082A1 (ja) * 2007-02-28 2010-06-03 イビデン株式会社 ハニカム構造体
WO2008105081A1 (ja) * 2007-02-28 2008-09-04 Ibiden Co., Ltd. ハニカムフィルタ
JP5241235B2 (ja) * 2007-02-28 2013-07-17 イビデン株式会社 ハニカム構造体の製造方法
WO2008126334A1 (ja) * 2007-03-30 2008-10-23 Ibiden Co., Ltd. ハニカム構造体の製造方法
WO2008126333A1 (ja) * 2007-03-30 2008-10-23 Ibiden Co., Ltd. ハニカム構造体
KR101025465B1 (ko) * 2007-03-30 2011-04-04 이비덴 가부시키가이샤 허니컴 구조체 및 허니컴 구조체의 제조 방법
WO2008139608A1 (ja) * 2007-05-14 2008-11-20 Ibiden Co., Ltd. ハニカム構造体及び該ハニカム構造体の製造方法

Also Published As

Publication number Publication date
WO2002010152A3 (de) 2002-08-01
AU2001289758B2 (en) 2006-07-06
US20080108819A1 (en) 2008-05-08
US20080153875A1 (en) 2008-06-26
KR100810453B1 (ko) 2008-03-07
IL153930A (en) 2008-11-03
ES2303532T3 (es) 2008-08-16
CN1215066C (zh) 2005-08-17
NO20030382D0 (no) 2003-01-24
CY1108770T1 (el) 2014-04-09
BG107560A (bg) 2003-10-31
US7989453B2 (en) 2011-08-02
SK288085B6 (sk) 2013-06-03
PL208673B1 (pl) 2011-05-31
SI1309585T1 (sl) 2008-08-31
NZ524404A (en) 2004-08-27
CA2704691A1 (en) 2002-01-28
AU8975801A (en) 2002-02-13
HK1058201A1 (en) 2004-05-07
CA2354210A1 (en) 2002-01-28
KR20030017658A (ko) 2003-03-03
CZ304197B6 (cs) 2013-12-27
TWI291955B (en) 2008-01-01
IL153930A0 (en) 2003-07-31
ZA200300584B (en) 2003-07-18
CN1447805A (zh) 2003-10-08
HUP0300677A2 (hu) 2003-11-28
DE10037310A1 (de) 2002-02-07
MXPA03000644A (es) 2003-06-06
RU2270196C9 (ru) 2007-11-27
RU2270196C2 (ru) 2006-02-20
EP2163552A1 (de) 2010-03-17
US7365081B2 (en) 2008-04-29
CA2354210C (en) 2010-09-14
JP2004505075A (ja) 2004-02-19
US8008324B2 (en) 2011-08-30
CA2704693A1 (en) 2002-01-28
PL361356A1 (en) 2004-10-04
AR055209A1 (es) 2007-08-15
WO2002010152A2 (de) 2002-02-07
JP5113973B2 (ja) 2013-01-09
EP1939195A1 (de) 2008-07-02
NO324594B1 (no) 2007-11-26
DE50113867D1 (de) 2008-05-29
ATE392420T1 (de) 2008-05-15
EP1309585B1 (de) 2008-04-16
NO20030382L (no) 2003-02-20
US20030100597A1 (en) 2003-05-29
BG66457B1 (bg) 2014-10-31
SK2222003A3 (en) 2004-04-06
UA80670C2 (en) 2007-10-25
CZ2003500A3 (cs) 2004-03-17
PT1309585E (pt) 2008-06-09
HU229254B1 (en) 2013-10-28
EP1309585A2 (de) 2003-05-14
BR0112807A (pt) 2003-07-01

Similar Documents

Publication Publication Date Title
NO20030301D0 (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
NO20051645L (no) Nye aminoindozolderivater som medisin og farmakologiske preparater inneholdende disse
NO20030302L (no) Nye heteroarylderivater og deres anvendelse som medikamenter
NO20035193D0 (no) Nye pyrrolderivater som farmasöytiske midler
DK1309585T3 (da) Nye indolderivater og anvendelse af disse som lægemidler
NO20030298D0 (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
DK1498413T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20034187L (no) Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
NO20031952L (no) 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
NO20013809D0 (no) Indolderivater og anvendelse derav som MCP-1 antagonister
NO20022289D0 (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1309575T3 (da) Biphenylderivater og deres anvendelse som aktivatorer af PPAR-gamma-receptorerne
NO20032830D0 (no) Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer
NO20045064L (no) Indol-, azaindol- og beslektede heterocykliske 4-alkenyl-piperidin-amider
NO20034970D0 (no) Nye arylheteroalkylaminderivater
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
DK1500654T3 (da) Benzoxazinonderivater, fremstilling deraf og anvendelse deraf som lægemidler
NO20044665L (no) Renzoksazin-derivater som 5-HT6-modulatorer og anvendelser derav
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
NO20025504L (no) Nye tiokromanderivater og anvendelse derav som trombininhibitorer
DK1551814T3 (da) Chirale oxazol-arylpropionsyrederivater og anvendelse deraf som ppar-agnister
NO20030998L (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
IS8383A (is) Nýjar afleiður af 4a,5,9,10,11,12-hexahýdróbensófúró[3a,3,2][2]-bensasepín, aðferð við framleiðslu þeirra og notkun þeirra við framleiðslu á lyfjum